SNCA and neurodegenerative disease: Moreover, the compounds stimulated theproteasome to degrade model protein substrates involved in the developmentof neurodegenerative diseases, α-synuclein, and tau protein.In studies conducted with a mouse embryonic cell model, the activatorseffectively reduced the level of α-synuclein aggregates in thehippocampal neurons.